Skip to main content
. Author manuscript; available in PMC: 2017 May 12.
Published in final edited form as: Am J Nephrol. 2016 May 12;43(5):325–333. doi: 10.1159/000445757

Appendix Table 8.

Association of eGFR and Cardiovascular Mortality by Quartile of eGFR

Relative Hazard (95% Confidence Interval)
Estimating Equation
Category (mL/min/1.73m2)
Age Adjusted Incidence Rate per
1,000 PersonYears (95% CI)
Unadjusted Base Model* Final Model**
CKD-EPIcr, cysc
 Q4: ≥83 6.45 (3.85, 9.05) 1.00 (referent) 1.00 (referent) 1.00 (referent)
 Q3:71 to <83 9.32 (6.61, 12.03) 1.76 (1.11, 2.77) 1.34 (0.84, 2.12) 1.31 (0.82, 2.09)
 Q2:58 to <71 11.60 (8.08, 15.12) 2.23 (1.44, 3.46) 1.43 (0.91, 2.25) 1.33 (0.84, 2.11)
 Q1:<58 18.24 (14.28, 22.19) 4.95 (3.31, 7.41) 2.44 (1.58, 3.77) 1.92 (1.23, 2.99)
 p-trend <0.001 <0.001 0.002
BIS2
 Q4: ≥71 8.96 (4.09, 13.84) 1.00 (referent) 1.00 (referent) 1.00 (referent)
 Q3:63 to <71 10.24 (7.30, 13.18) 1.82 (1.16, 2.86) 1.43 (0.90, 2.27) 1.42 (0.89, 2.27)
 Q2:53 to <63 10.94 (7.42, 14.47) 2.03 (1.30, 3.17) 1.31 (0.82, 2.08) 1.23 (0.77, 1.97)
 Q1:<53 18.08 (14.10, 22.07) 5.18 (3.47, 7.74) 2.43 (1.55, 3.81) 1.89 (1.20, 2.98)
 p-trend <0.001 <0.001 0.008
CKD-EPIcr
 Q4: ≥82 9.75 (5.77, 13.72) 1.00 (referent) 1.00 (referent) 1.00 (referent)
 Q3: 73 to <82 9.50 (6.85, 12.15) 1.29 (0.86, 1.94) 0.88 (0.58, 1.34) 0.83 (0.54, 1.28)
 Q2:61 to <73 10.96 (8.12, 13.80) 1.56 (1.05, 2.32) 0.99 (0.65, 1.49) 0.94 (0.62, 1.43)
 Q1:<61 15.09 (11.93, 18.25) 2.88 (2.01, 4.14) 1.43 (0.96, 2.12) 1.13 (0.75, 1.70)
 p-trend <0.001 0.014 0.22
CKD-EPIcysc
 Q4:≥82 8.75 (4.57, 12.94) 1.00 (referent) 1.00 (referent) 1.00 (referent)
 Q3:67 to <82 9.42 (6.54, 12.31) 1.56 (1.00, 2.45) 1.23 (0.78, 1.94) 1.21 (0.77, 1.92)
 Q2:53 to <67 10.93 (7.49, 14.37) 1.96 (1.27, 3.03) 1.20 (0.76, 1.88) 1.12 (0.71, 1.77)
 Q1:<53 19.69 (15.50, 23.89) 4.90 (3.31, 7.25) 2.39 (1.56, 3.66) 1.84 (1.19, 2.85)
 p-trend <0.001 <0.001 0.003

Abbreviations: eGFR, estimated glomerular filtration rate; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; cr, creatinine; cysc, cystatin c; BIS, Berlin Initiative Study

*

adjusted for age, race, and body mass index

**

adjusted for age, race, body mass index, hypertension, diabetes mellitus, congestive heart failure, coronary heart disease, and stroke